Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Marzena Anna Lewandowska"'
Autor:
Karolina Wegrzynska, Jaroslaw Walory, Radoslaw Charkiewicz, Marzena Anna Lewandowska, Izabela Wasko, Aleksandra Kozinska, Piotr Majewski, Anna Baraniak
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 493 (2023)
Accurate and rapid identification of COVID-19 is critical for effective patient treatment and disease outcomes, as well as the prevention of SARS-CoV-2 transmission. Rapid antigen tests (RATs) for identifying SARS-CoV-2 are simpler, faster and less e
Externí odkaz:
https://doaj.org/article/56dd37f1adb5414384dece58acb2ace3
Autor:
Marzena Anna Lewandowska, Ewelina Nalejska, Łukasz Żołna, Aleksandra Chrząstek, Bogdan Żurawski, Magdalena Wiśniewska, Manuela Las-Jankowska, Krzysztof Roszkowski, Janusz Kowalewski
Publikováno v:
Contemporary Oncology, Vol 23, Iss 2, Pp 87-91 (2019)
Externí odkaz:
https://doaj.org/article/1562afdb5dee46b69005effa45cf41f8
Use of Fluorescence In Situ Hybridization (FISH) in Diagnosis and Tailored Therapies in Solid Tumors
Publikováno v:
Molecules, Vol 25, Iss 8, p 1864 (2020)
Fluorescence in situ hybridization (FISH) is a standard technique used in routine diagnostics of genetic aberrations. Thanks to simple FISH procedure is possible to recognize tumor-specific abnormality. Its applications are limited to designed probe
Externí odkaz:
https://doaj.org/article/625fc7ecfeb04f39af6035e41c4b123f
Autor:
Marzena Anna Lewandowska, Karol Czubak, Katarzyna Klonowska, Wojciech Jozwicki, Janusz Kowalewski, Piotr Kozlowski
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0117983 (2015)
Lung cancer is the leading cause of cancer-related death worldwide. Recent progress in lung cancer diagnosis and treatment has been achieved due to a better understanding the molecular mechanisms of the disease and the identification of biomarkers th
Externí odkaz:
https://doaj.org/article/5a642e35faf44b4abacb5cdcb5c0af2e
Autor:
Marzena Anna Lewandowska, Jacek Furtak, Janusz Kowalewski, Paulina Śledzińska, Marek G. Bebyn
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 10373, p 10373 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 10373, p 10373 (2021)
Gliomas are the most common central nervous system tumors. New technologies, including genetic research and advanced statistical methods, revolutionize the therapeutic approach to the patient and reveal new points of treatment options. Moreover, the
Publikováno v:
Oncology Reports
Large‑scale projects, such as The Cancer Genome Atlas (TCGA), Human Epigenome Project (HEP) and Human Epigenome Atlas (HEA), provide an insight into DNA methylation and histone modification markers. Changes in the epigenome significantly contribute
Autor:
Marzena Anna Lewandowska, Krzysztof Roszkowski, Katarzyna Białożyk-Mularska, Zofia Roszkowska, Sylwia Szablewska
Publikováno v:
Medical Research Journal. 4:8-12
Background: Patients with advanced non-small cell lung cancer (NSCLC) are candidates for different types of treatment, including chemotherapy and radiotherapy or supportive care. Despite the fatal prognosis in advanced disease, many experienced radia
Autor:
Łukasz Żołna, Aleksandra Chrząstek, Bogdan Żurawski, Ewelina Nalejska, Magdalena Wiśniewska, Janusz Kowalewski, Marzena Anna Lewandowska, Krzysztof Roszkowski, Manuela Las-Jankowska
Publikováno v:
Contemporary Oncology
Contemporary Oncology, Vol 23, Iss 2, Pp 87-91 (2019)
Contemporary Oncology, Vol 23, Iss 2, Pp 87-91 (2019)
Aim of the study The main purpose of this study was to assess detection of mutations in the epidermal growth factor receptor (EGFR) gene in circulating tumor DNA (ctDNA) as a tool for EGFR tyrosine kinase inhibitor (TKI) monitoring therapy. Material
Publikováno v:
Physical Sciences Reviews.
Biomarker is defined as indicator of normal or pathogenic biological process or response to an intervention or exposure. There are several categories of biomarkers but predictive biomarkers play the most important role in the treatment of neoplasms.
Autor:
Marzena Anna Lewandowska, Janusz Kowalewski, Katarzyna Kamińska, Marcin Misiek, Ewelina Szczerba, Tomasz Mierzwa
Publikováno v:
Genes
Volume 12
Issue 4
Genes, Vol 12, Iss 519, p 519 (2021)
Volume 12
Issue 4
Genes, Vol 12, Iss 519, p 519 (2021)
(1) Background: Although, in the mutated BRCA detected in the Polish population of patients with breast cancer, there is a large percentage of recurrent pathogenic variants, an increasing need for the assessment of rare BRCA1/2 variants using NGS can